These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 24942029)
21. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Marsh RA; Rao K; Satwani P; Lehmberg K; Müller I; Li D; Kim MO; Fischer A; Latour S; Sedlacek P; Barlogis V; Hamamoto K; Kanegane H; Milanovich S; Margolis DA; Dimmock D; Casper J; Douglas DN; Amrolia PJ; Veys P; Kumar AR; Jordan MB; Bleesing JJ; Filipovich AH Blood; 2013 Feb; 121(6):877-83. PubMed ID: 23131490 [TBL] [Abstract][Full Text] [Related]
22. IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH. O'Rafferty C; Velangi M; Lawson S; Hiwarkar P; Motwani J J Clin Immunol; 2017 Aug; 37(6):511-513. PubMed ID: 28639166 [No Abstract] [Full Text] [Related]
23. Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. Mickelson DM; Sproat L; Dean R; Sobecks R; Rybicki L; Kalaycio M; Pohlman B; Sweetenham J; Andresen S; Bolwell B; Copelan EA Bone Marrow Transplant; 2011 Jan; 46(1):84-9. PubMed ID: 20305699 [TBL] [Abstract][Full Text] [Related]
24. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults. Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796 [TBL] [Abstract][Full Text] [Related]
25. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214 [TBL] [Abstract][Full Text] [Related]
26. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545 [TBL] [Abstract][Full Text] [Related]
27. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation? Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165 [TBL] [Abstract][Full Text] [Related]
28. Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure. Mohamedbhai SG; Edwards N; Morris EC; Mackinnon S; Thomson KJ; Peggs KS Br J Haematol; 2012 Feb; 156(4):516-22. PubMed ID: 22171699 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578 [TBL] [Abstract][Full Text] [Related]
30. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis. Cesaro S; Gazzola MV; Marson P; Calore E; Caenazzo L; Destro R; De Silvestro G; Varotto S; Pillon M; Zanesco L; Messina C Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin. Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582 [TBL] [Abstract][Full Text] [Related]
32. XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice. Müller N; Fischer JC; Yabal M; Haas T; Poeck H; Jost PJ Eur J Immunol; 2019 Mar; 49(3):504-507. PubMed ID: 30585320 [TBL] [Abstract][Full Text] [Related]
33. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma. Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972 [TBL] [Abstract][Full Text] [Related]
34. X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis. Steele CL; Doré M; Ammann S; Loughrey M; Montero A; Burns SO; Morris EC; Gaspar B; Gilmour K; Bibi S; Shendi H; Devlin L; Speckmann C; Edgar DM J Clin Immunol; 2016 Oct; 36(7):733-8. PubMed ID: 27492372 [TBL] [Abstract][Full Text] [Related]
35. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency. Yang L; Booth C; Speckmann C; Seidel MG; Worth AJJ; Kindle G; Lankester AC; Grimbacher B; ; Gennery AR; Seppanen MRJ; Morris EC; Burns SO J Allergy Clin Immunol; 2022 Aug; 150(2):456-466. PubMed ID: 34920033 [TBL] [Abstract][Full Text] [Related]